Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance.

Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, Thitai AK, Oh J, Volgin A, Soghomonyan S, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Mushkudiani I, Kuno N, Krishnan S, Bornman W, Lai SY, Powis G, Hazle J, Gelovani J.

Mol Cancer Res. 2011 Mar;9(3):259-70. doi: 10.1158/1541-7786.MCR-10-0469. Epub 2011 Mar 1.

2.

How can we overcome tumor hypoxia in radiation therapy?

Harada H.

J Radiat Res. 2011;52(5):545-56. Review.

3.

Raising the bar: how HIF-1 helps determine tumor radiosensitivity.

Moeller BJ, Dewhirst MW.

Cell Cycle. 2004 Sep;3(9):1107-10. Epub 2004 Sep 20. Review.

PMID:
15326390
4.

HIF-1 and tumour radiosensitivity.

Moeller BJ, Dewhirst MW.

Br J Cancer. 2006 Jul 3;95(1):1-5. Epub 2006 May 30. Review.

5.

Modulating the tumor microenvironment to increase radiation responsiveness.

Karar J, Maity A.

Cancer Biol Ther. 2009 Nov;8(21):1994-2001. Epub 2009 Nov 3. Review.

6.

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.

Barker HE, Paget JT, Khan AA, Harrington KJ.

Nat Rev Cancer. 2015 Jul;15(7):409-25. doi: 10.1038/nrc3958. Review. Erratum in: Nat Rev Cancer. 2015 Aug;15(8):509.

Supplemental Content

Support Center